Clinical Trials Arena on MSN
Lynk’s selective JAK inhibitor claims Phase III RA win
Lynk’s zemprocitinib commercial partner, Simcere, will now continue the JAK inhibitor’s development across China in RA.
Combining an anticancer drug with an antirheumatic produces improved effects against tumors, scientists have discovered. The discovery opens a new path for drug-drug synergy. Scientists at EPFL and ...
Treatment with biologic DMARDs vs standard therapy improved clinical response rates and flare outcomes among patients with polyarticular JIA.
Early therapeutic interventions in inflammatory rheumatic diseases have proven successful in inducing drug-free remission, and EULAR—The European Alliance of Associations for Rheumatology—recommends ...
Scientists at EPFL and NTU have discovered that combining an anticancer drug with an antirheumatic produces improved effects against tumors. The discovery opens a new path for drug-drug synergy. One ...
Only slightly more than half of patients with newly diagnosed rheumatoid arthritis initiated therapy within 1 year. Objectives: To determine the rate of timely disease-modifying antirheumatic drug ...
The autoimmune disorder rheumatoid arthritis has been associated with a lower risk of Parkinson’s disease (PD) in previous studies, with antirheumatic drugs as one possible explanation. However, most ...
In 2016, EULAR - The European Alliance of Associations for Rheumatology - published points-to-consider on the use of antirheumatic drugs in reproduction, pregnancy, and lactation. Since then, new ...
Patients with RA have a higher risk of developing disease-related lymphoma than the general population. Patients with more severe RA have higher cumulative disease activity and are more likely to be ...
The introduction of new therapies for rheumatoid arthritis (RA) has led to concerns about treatment-related adverse events, particularly malignancy and cardiovascular disease. Many published reports ...
WASHINGTON — At the American College of Rheumatology Annual Meeting, the American College of Rheumatology, in partnership with the American Association of Hip and Knee Surgeons, presented joint ...
Antipsychotic Use Up Among U.S. Medicaid-Enrolled Youth The use of a disease-modifying antirheumatic drug (DMARD) during pregnancy is rare and is associated with a nonsignificant increase in the risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results